Mean Platelet Volume Predicts Short-term Prognosis in Young Patients with St-segment Elevation Myocardial Infarction

1. Mensah GA, Wei GS, Sorlie PD, et al. Decline in Cardiovascular Mortality: Possible Causes and Implications. Circ Res. 2017;120:366-380. doi: 10.1161/CIRCRESAHA.116.309115.10.1161/CIRCRESAHA.116.309115Open DOISearch in Google Scholar

2. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459-1544. doi: 10.1016/S0140-6736(16)31012-1.10.1016/S0140-6736(16)31012-1Open DOISearch in Google Scholar

3. Roth GA, Huffman MD, Moran AE, et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation. 2015;132:1667-1678. doi: 10.1161/CIRCULATIONAHA.114.008720.10.1161/CIRCULATIONAHA.114.00872026503749Open DOISearch in Google Scholar

4. Bajaj S, Shamoon F, Gupta N, et al. Acute ST-segment elevation myocardial infarction in young adults: who is at risk? Coron Artery Dis. 2011;22:238-244. doi: 10.1097/MCA.0b013e3283452e7f.10.1097/MCA.0b013e3283452e7f21407075Open DOISearch in Google Scholar

5. Lautamaki A, Airaksinen KEJ, Kiviniemi T, et al. Prognosis and disease progression in patients under 50 years old undergoing PCI: The CRAGS (Coronary aRtery diseAse in younG adultS) study. Atherosclerosis. 2014;235:483-487. doi: 10.1016/j.atherosclerosis.2014.05.953.10.1016/j.atherosclerosis.2014.05.95324953487Open DOISearch in Google Scholar

6. Jinnouchi H, Sakakura K, Wada H, et al. Clinical features of myocardial infarction in young Japanese patients. Int Heart J. 2013;54:123-128.10.1536/ihj.54.12323774233Search in Google Scholar

7. Oliveira A, Barros H, Maciel MJ, Lopes C. Tobacco smoking and acute myocardial infarction in young adults: a population-based case-control study. Prev Med. 2007;44:311-316. doi: 10.1016/j.ypmed.2006.12.002.10.1016/j.ypmed.2006.12.00217239433Open DOISearch in Google Scholar

8. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Patients. Third report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Patients (Adult Treatment Panel III): final report. Circulation. 2002;106:3143-3421.10.1161/circ.106.25.3143Search in Google Scholar

9. Chung EH, Curran PJ, Sivasankaran S, et al. Prevalence of metabolic syndrome in patients ≤45 years of age with acute myocardial infarction having percutaneous coronary intervention. Am J Cardiol. 2007;100:1052-1055. doi: 10.1016/j.amjcard.2007.05.028.10.1016/j.amjcard.2007.05.02817884360Open DOISearch in Google Scholar

10. Singh A, Collins B, Qamar A, et al. Study of young patients with myocardial infarction: Design and rationale of the YOUNG-MI Registry. Clin Cardiol. 2017;40:955-961. doi: 10.1002/clc.22774.10.1002/clc.22774576165328805969Search in Google Scholar

11. Konishi H, Miyauchi K, Kasai T, Tsuboi S, Ogita M, Naito R. Long-term prognosis and clinical characteristics of young adults (≤40 years old) who underwent percutaneous coronary intervention. J Cardiol. 2014;64:171-174. doi: 10.1016/j.jjcc.2013.12.005.10.1016/j.jjcc.2013.12.005Open DOISearch in Google Scholar

12. Meliga E, De Benedictis M, Gagnor A, Belli R, Scrocca I, Lombardi P. Long-term outcomes of percutaneous coronary interventions with stent implantation in patients ≤40 years old. Am J Cardiol. 2012;109:1717-1721. doi: 10.1016/j.amjcard.2012.01.400.10.1016/j.amjcard.2012.01.400Open DOISearch in Google Scholar

13. Berger JS, Eraso LH, Xie D, Sha D, Mohler ER 3rd. Mean platelet volume and prevalence of peripheral artery disease, the National Health and Nutrition Examination Survey 1999-2004. Atherosclerosis 2010;213:586-591. doi: 10.1016/j.atherosclerosis.2010.09.010.10.1016/j.atherosclerosis.2010.09.010Open DOISearch in Google Scholar

14. Pizzulli L, Yang A, Martin JF, Luderitz B. Changes in platelet size and count in unstable angina compared to stable angina or non-cardiac chest pain. Eur Heart J. 1998;19:80-84. doi: 10.1053/euhj.1997.0747.10.1053/euhj.1997.0747Open DOISearch in Google Scholar

15. Varol E, Aksoy F, Özaydın M, Erdoğan D, Doğan A. Relationship between mean platelet volume and mitral annular calcification. Blood Coagul Fibrinolysis. 2013;24:189-193. doi: 10.1097/MBC.0b013e32835b7296.10.1097/MBC.0b013e32835b7296Open DOISearch in Google Scholar

16. Huczek Z, Kochman J, Filipak KJ et al. Mean platelet volume on admission predicts impaired reperfusion and long-term mortality in acute myocardial infarction treated with primary percutaneous coronary intervention. J Am Coll Cardiol. 2005;46:284-290. doi: 10.1016/j.jacc.2005.03.065.10.1016/j.jacc.2005.03.065Open DOISearch in Google Scholar

17. Tomasz R, Aleksandra J, Jakub F, et al. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention. Cardiol J. 2013;20:491-498. doi: 10.5603/CJ.2013.0134.10.5603/CJ.2013.0134Open DOISearch in Google Scholar

18. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.10.7326/0003-4819-150-9-200905050-00006Search in Google Scholar

19. Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20:457-464.10.1016/0002-9149(67)90023-9Search in Google Scholar

20. Sianos G, Papafaklis MI, Serruys PW. Angiographic thrombus burden classification in patients with ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. J Invasive Cardiol. 2010;22:6B-14B.Search in Google Scholar

21. Kirma C, Izgi A, Dundar C, et al. Clinical and procedural predictors of no-reflow phenomenon after primary percutaneous coronary interventions: experience at a single center. Circ J. 2008;72:716-721.10.1253/circj.72.71618441449Search in Google Scholar

22. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography-summary article: a report of the American college of cardiology/American heart association task force on practice guidelines (ACC/AHA/ASE committee to update the 1997 guidelines for the clinical application of echocardiography). J Am Coll Cardiol. 2003;42:954-970.10.1016/S0735-1097(03)01065-9Search in Google Scholar

23. Braunwald E. Coronary plaque erosion: recognition and management. JACC Cardiovasc Imaging. 2013;6:288-289. doi: 10.1016/j.jcmg.2013.01.003.10.1016/j.jcmg.2013.01.00323473110Open DOISearch in Google Scholar

24. Kolodgie FD, Burke AP, Farb A, et al. Plaque erosion. In: Virmani R, Narula J, Leon MB, Willerson JT, editors. The Vulnerable Atherosclerotic Plaque: Strategies for Diagnosis and Management. Boston, MA: Blackwell Publishing, 2007; p. 60-76.10.1002/9780470987575.ch4Search in Google Scholar

25. Dai J, Xing L, Jia H, et al. In vivo predictors of plaque erosion in patients with ST-segment elevation myocardial infarction: a clinical, angiographical, and intravascular optical coherence tomography study. Eur Heart J. 2018;39:2077-2085. doi: 10.1093/eurheartj/ehy101.10.1093/eurheartj/ehy10129547992Open DOISearch in Google Scholar

26. Mincu RI, Jánosi RA, Vinereanu D, Rassaf T, Totzeck M. Preprocedural C-Reactive Protein Predicts Outcomes after Primary Percutaneous Coronary Intervention in Patients with ST-elevation Myocardial Infarction a systematic meta-analysis. Sci Rep. 2017;7:41530. doi: 10.1038/srep41530.10.1038/srep41530527024428128312Search in Google Scholar

27. Sawant AC, Adhikari P, Narra SR, Srivatsa SS, Mills PK, Srivatsa SS. Neutrophil to lymphocyte ratio predicts short-and long-term mortality following revascularization therapy for ST elevation myocardial infarction. Cardiol J. 2014;21:500-508. doi: 10.5603/CJ.a2013.0148.10.5603/CJ.a2013.014824142685Open DOISearch in Google Scholar

28. Park JJ, Jang HJ, Oh IY, et al. Prognostic value of neutrophil to lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013;111:636-642. doi: 10.1016/j.amjcard.2012.11.012.10.1016/j.amjcard.2012.11.01223273716Open DOISearch in Google Scholar

29. Machado GP, Araujo GN, Carpes CK, et al. Comparison of neutrophil-to-lymphocyte ratio and mean platelet volume in the prediction of adverse events after primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction. Atherosclerosis. 2018;274:212-217. doi: 10.1016/j.atherosclerosis.2018.05.022.10.1016/j.atherosclerosis.2018.05.02229803159Open DOISearch in Google Scholar

30. Toprak C, Tabakci MM, Simsek Z, Arslantas U, Durmus HI, Ocal L. Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention. Postepy Kardiol Interwencyjnej. 2015;11:288-297. doi: 10.5114/pwki.2015.55599.10.5114/pwki.2015.55599467979626677378Open DOISearch in Google Scholar

31. Ozcan Cetin EH, Cetin MS, Aras D, et al. Platelet to Lymphocyte Ratio as a Prognostic Marker of In-Hospital and Long-Term Major Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction. Angiology. 2016;67:336-345. doi: 10.1177/0003319715591751.10.1177/000331971559175126101368Open DOISearch in Google Scholar

32. Karataş MB, Çanga Y, Özcan KS, et al. Monocyte to high-density lipoprotein ratio as a new prognostic marker in patients with STEMI undergoing primary percutaneous coronary intervention. Am J Emerg Med. 2016;34:240-244. doi: 10.1016/j.ajem.2015.10.049.10.1016/j.ajem.2015.10.04926585199Open DOISearch in Google Scholar

33. Libby P, Pasterkamp G, Crea F, Jang IK. Reassessing the Mechanisms of Acute Coronary Syndromes The “Vulnerable Plaque” and Superficial Erosion. Circ Res. 2019;124:150-160. https://doi.org/10.1161/CIRCRESAHA.118.311098.10.1161/CIRCRESAHA.118.311098644737130605419Open DOISearch in Google Scholar

34. Campbell IC, Suever JD, Timmins LH, et al. Biomechanics and inflammation in atherosclerotic plaque erosion and plaque rupture: implications for cardiovascular events in women. PLoS One. 2014;9:e111785. doi: 10.1371/journal.pone.0111785.10.1371/journal.pone.0111785421881825365517Search in Google Scholar

35. Niccoli G, Montone RA, Cataneo L, et al. Morphological-biohumoral correlations in acute coronary syndromes: pathogenetic implications. Int J Cardiol. 2014;171:463-466. doi: 10.1016/j.ijcard.2013.12.238.10.1016/j.ijcard.2013.12.23824439867Open DOISearch in Google Scholar

36. Ferrante G, Nakano M, Prati F, et al. High levels of systemic myeloperoxidase are associated with coronary plaque erosion in patients with acute coronary syndromes: a clinicopathological study. Circulation. 2010;122:2505-2513. doi: 10.1161/CIRCULATIONAHA.110.955302.10.1161/CIRCULATIONAHA.110.95530221126969Open DOISearch in Google Scholar

37. Saia F, Komukai K, Capodanno D, Sirbu V, Musumeci G, Boccuzzi G. Eroded Versus Ruptured Plaques at the Culprit Site of STEMI: In Vivo Pathophysiological Features and Response to Primary PCI. JACC Cardiovasc Imaging. 2015;8:566-575. doi: 10.1016/j.jcmg.2015.01.018.10.1016/j.jcmg.2015.01.01825890582Search in Google Scholar

38. Sianos, G, Papafaklis, MI, Daemen, J. Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol. 2007;50:573-583. doi: 10.1016/j.jacc.2007.04.059.10.1016/j.jacc.2007.04.05917692740Open DOISearch in Google Scholar

39. Kamath S, Blann AD, Lip GY. Platelet activation: assessment and quantification. Eur Heart J. 2001;22:1561-1571. doi: 10.1053/euhj.2000.2515.10.1053/euhj.2000.251511492985Open DOISearch in Google Scholar

40. Grove EL, Hvas AM, Kristensen SD. Immature platelets in patients with acute coronary syndromes. Thromb Haemost. 2009;101:151-156.10.1160/TH08-03-0186Search in Google Scholar

41. Funck-Jensen KL, Dalsgaard J, Grove EL, Hvas AM, Kristensen SD. Increased platelet aggregation and turnover in the acute phase of ST-elevation myocardial infarction. Platelets. 2013;24:528-537. doi: 10.3109/09537104.2012.738838.10.3109/09537104.2012.73883823216571Open DOISearch in Google Scholar

42. Tschoepe D, Roesen P, Esser J, et al. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost. 1991;17:433-438. doi: 10.1055/s-2007-1002650.10.1055/s-2007-10026501803514Open DOISearch in Google Scholar

43. Debili N, Masse JM, Katz A, Guichard J, Breton-Gorius J, Vainchenker W. Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells. Blood. 1993;82:84-95.10.1182/blood.V82.1.84.bloodjournal82184Search in Google Scholar

44. Tekbas E, Kara AF, Ariturk Z, et al. Mean platelet volume in predicting short- and long-term morbidity and mortality in patients with or without ST-segment elevation myocardial infarction. Scand J Clin Lab Invest. 2011;71:613-619. doi: 10.3109/00365513.2011.599416.10.3109/00365513.2011.59941621859357Open DOISearch in Google Scholar

45. Ranjith MP, DivyaRaj R, Mathew D, George B, Krishnan MN. Mean platelet volume and cardiovascular outcomes in acute myocardial infarction. Heart Asia. 2016;8:16-20. doi: 10.1136/heartasia-2015-010696.10.1136/heartasia-2015-010696489862527326224Open DOISearch in Google Scholar